Your browser doesn't support javascript.
loading
Response criteria for intraocular retinoblastoma: RB-RECIST.
Berry, Jesse L; Munier, Francis L; Gallie, Brenda L; Polski, Ashley; Shah, Sona; Shields, Carol L; Gombos, Dan S; Ruchalski, Kathleen; Stathopoulos, Christina; Shah, Rachana; Jubran, Rima; Kim, Jonathan W; Mruthyunjaya, Prithvi; Marr, Brian P; Wilson, Matthew W; Brennan, Rachel C; Chantada, Guillermo L; Chintagumpala, Murali M; Murphree, A Linn.
Afiliação
  • Berry JL; The Vision Center at Children's Hospital Los Angeles, Los Angeles, California, USA.
  • Munier FL; USC Roski Eye Institute, Keck School of Medicine of the University of Southern California, Los Angeles, California, USA.
  • Gallie BL; Jules-Gonin Eye Hospital, Fondation Asile des Aveugles, University of Lausanne, Lausanne, Switzerland.
  • Polski A; Department of Ophthalmology & Vision Sciences, University of Toronto, Toronto, Ontario, Canada.
  • Shah S; Department of Ophthalmology & Vision Sciences, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Shields CL; Departments of Molecular Genetics & Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
  • Gombos DS; The Vision Center at Children's Hospital Los Angeles, Los Angeles, California, USA.
  • Ruchalski K; USC Roski Eye Institute, Keck School of Medicine of the University of Southern California, Los Angeles, California, USA.
  • Stathopoulos C; The Vision Center at Children's Hospital Los Angeles, Los Angeles, California, USA.
  • Shah R; USC Roski Eye Institute, Keck School of Medicine of the University of Southern California, Los Angeles, California, USA.
  • Jubran R; Ocular Oncology Service, Wills Eye Hospital, Philadelphia, Pennsylvania, USA.
  • Kim JW; Department of Head & Neck Surgery, Division of Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Mruthyunjaya P; Department of Radiology, David Geffen School of Medicine at University of California, Los Angeles, California, USA.
  • Marr BP; Jules-Gonin Eye Hospital, Fondation Asile des Aveugles, University of Lausanne, Lausanne, Switzerland.
  • Wilson MW; Cancer and Blood Disease Institute at Children's Hospital Los Angeles, Los Angeles, California, USA.
  • Brennan RC; Cancer and Blood Disease Institute at Children's Hospital Los Angeles, Los Angeles, California, USA.
  • Chantada GL; The Vision Center at Children's Hospital Los Angeles, Los Angeles, California, USA.
  • Chintagumpala MM; USC Roski Eye Institute, Keck School of Medicine of the University of Southern California, Los Angeles, California, USA.
  • Murphree AL; Department of Ophthalmology, Stanford Byers Eye Institute, Palo Alto, California, USA.
Pediatr Blood Cancer ; 68(5): e28964, 2021 05.
Article em En | MEDLINE | ID: mdl-33624399
ABSTRACT
Standardized guidelines for assessing tumor response to therapy are essential for designing and conducting clinical trials. The Response Evaluation Criteria In Solid Tumors (RECIST) provide radiological standards for assessment of solid tumors. However, no such guidelines exist for the evaluation of intraocular cancer, and ocular oncology clinical trials have largely relied on indirect measures of therapeutic response-such as progression-free survival-to evaluate the efficacy of treatment agents. Herein, we propose specific criteria for evaluating treatment response of retinoblastoma, the most common pediatric intraocular cancer, and emphasize a multimodal imaging approach for comprehensive assessment of retinoblastoma tumors in clinical trials.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Retinoblastoma / Neoplasias da Retina / Critérios de Avaliação de Resposta em Tumores Sólidos Tipo de estudo: Guideline Limite: Humans Idioma: En Revista: Pediatr Blood Cancer Assunto da revista: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Retinoblastoma / Neoplasias da Retina / Critérios de Avaliação de Resposta em Tumores Sólidos Tipo de estudo: Guideline Limite: Humans Idioma: En Revista: Pediatr Blood Cancer Assunto da revista: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos